Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271590 · ClinicalTrials.gov registry record · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
A NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by Concept Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 1,605
- Enrollment target
- 20
- Study locations
NCT06271590: Recruiting NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by Concept Medical.
NCT06271590 is a NA study of Cardiovascular Diseases and Coronary Artery Disease that is actively recruiting participants, run by Concept Medical. The registered enrollment target is 1,605 participants, below the 26,969-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06271590, a NA study of Cardiovascular Diseases and Coronary Artery Disease, is actively recruiting participants, sponsored by Concept Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,605 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated balloon in treatment of small vessels (≤2.75 mm). A total of 1605 subjects will be enrolled in a maximum of 50 study sites located in North America. Additional sites located in Europe and South America may also participate in the study, with non-US sites contributing a maximum of \~50% of enrollees.
Primary Outcome
the composite of cardiovascular mortality, target-vessel myocardial infarction (TV-MI) and ischemia driven target lesion revascularization
Conditions Studied
Interventions
- DEVICE Sirolimus Drug Coated Balloon
- DEVICE Drug eluting stents (DES)
Study Locations (20)
New York
- University Hospitals, Cleveland Medical Center - Brooklyn
- North Shore University Hospital - Northwell - Manhasset
- Icahn School of Medicine at Mount Sinai/ Mount Sinai Hospital - New York
- Columbia University/NYP - New York
- Montefiore Medical Center - The Bronx
Florida
- Clearwater Cardiovascular and Interventional Consultants - Clearwater
- University of Florida Health Sciences Center-Jacksonville - Jacksonville
- Tallahassee Research Institute - Tallahassee
- Tampa General Hospital / University of South Florida - Tampa
Georgia
- Emory University Hospital /Emory School of Medice - Atlanta
- Atlanta VA Medical Center - Decatur
Ohio
- University Hospitals, Cleveland Medical Center - Cleveland
- Cleveland Clinic - Cleveland
Arizona
- Dignity Health - Mercy Gilbert Medical Center - Gilbert
California
- Cedars-Sinai Medical Center - Los Angeles
Illinois
- Loyola University Medical Center - Maywood
Mississippi
- North Mississippi Medical Center - Tupelo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,605 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2031-11 |
| Phase | NA |
What NCT06271590 shows while recruiting
NCT06271590 is an interventional study that assigns participants to a tested intervention. Its 1,605 participants enrollment target places it among the larger protocols in the corpus, below the 26,969-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Sirolimus Drug Coated Balloon is the first listed.
NCT06271590 names 20 study sites across 11 states, led by New York, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT06271590 about?
NCT06271590 is a clinical study titled "MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels". This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated bal...
What is the current status of trial NCT06271590?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,605 participants. The study started on 2025-05-20. Estimated completion is 2031-11.
What conditions does trial NCT06271590 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Native Coronary Artery Stenosis.
What interventions are being tested in trial NCT06271590?
The interventions under investigation include: Sirolimus Drug Coated Balloon (DEVICE), Drug eluting stents (DES) (DEVICE).
Who is sponsoring clinical trial NCT06271590?
This trial is sponsored by Concept Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06271590 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06271590's enrollment target sits among peer trials
1,605 43rd of 300 higher than 258 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI